A primary reduced TCA flux governs substrate oxidation in T2D skeletal muscle

Current Diabetes Reviews

Volumn 8, Issue 6, 2012, Pages 458-479

  Gaster, Michael ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Glucose oxidation; Human; Insulin resistance; Lipid oxidation; Metabolic inflexibility; Mitochondria; Myotubes; Oxidative phosphorylation; Skeletal muscle; Tricarboxylic acid cycle; Type 2 diabetes

Indexed keywords

AMINO ACID; CARNITINE; FATTY ACID; GLUCOSE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 11; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 4; GLUTATHIONE PEROXIDASE; GLYCOGEN; GLYCOGEN SYNTHASE; HEXOKINASE; LACTATE DEHYDROGENASE; MANGANESE SUPEROXIDE DISMUTASE; OXALOACETIC ACID; PYRUVATE DECARBOXYLASE; PYRUVATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE; TRICARBOXYLIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CALORIMETRY; ENZYME ACTIVITY; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; GLYCOLYSIS; HUMAN; IN VIVO STUDY; INSULIN RESISTANCE; LIPID OXIDATION; MITOCHONDRION; MUSCLE METABOLISM; MYOTUBE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; OVARY POLYCYSTIC DISEASE; OXIDATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE;

BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELLS, CULTURED; CITRIC ACID CYCLE; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; OBESITY; OXIDATION-REDUCTION; OXIDATIVE STRESS; PHENOTYPE;

EID: 84870159746     PISSN: 15733998     EISSN: 18756417     Source Type: Journal    
DOI: 10.2174/157339912803529841     Document Type: Article

References (184)

1. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997; 14 Suppl 5: S1-85.
2. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001 Dec 13; 414(6865): 782-7.
3. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998 Sep; 21(9): 1414-31.
4. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med 1993 Jun 10; 328(23): 1676-85.
5. Kahn SE. The relative contributions of insulin resistance and betacell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 2003 Jan; 46(1): 3-19.
6. Beck-Nielsen H, Vaag A, Poulsen P, Gaster M. Metabolic and genetic influence on glucose metabolism in type 2 diabetic subjects--experiences from relatives and twin studies. Best Pract Res Clin Endocrinol Metab 2003 17(3): 445-67.
7. Beck-Nielsen H, Groop LC. Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulindependent diabetes mellitus. J Clin Invest 1994 Nov; 94(5): 1714-21.
8. Cusi K, Maezono K, Osman A, P et al. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 2000 Feb; 105(3): 311-20.
9. Gaster M, Ottosen PD, Vach W, et al. GLUT4 expression in human muscle fibres is not correlated with intracellular triglyceride (TG) content. Is TG a maker or a marker of insulin resistance? APMIS 2003 Feb; 111(2): 338-48.
10. Levin K, Daa SH, Alford FP, Beck-Nielsen H. Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes. Diabetologia 2001 Jul; 44(7): 824-33.
11. Eriksson J, Franssila-Kallunki A, et al. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 1989 Aug 10; 321(6): 337-43.
12. Schalin-Jantti C, Harkonen M, Groop LC. Impaired activation of glycogen synthase in people at increased risk for developing NIDDM. Diabetes 1992 May; 41(5): 598-604.
13. Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 1990 Jan 25; 322(4): 223-8.
14. Damsbo P, Vaag A, Hother-Nielsen O, Beck-Nielsen H. Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1991 Apr; 34(4): 239-45.
15. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002 Oct; 51(10): 2944-50.
16. Ritov VB, Menshikova EV, He J, Ferrell RE, Goodpaster BH, Kelley DE. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 2005 Jan; 54(1): 8-14.
17. Vaag A, Henriksen JE, Beck-Nielsen H. Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with noninsulin- dependent diabetes mellitus. J Clin Invest 1992 Mar; 89(3): 782-8.
18. Henry RR, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Park KS, Nikoulina SE. Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. Biochemical and molecular mechanisms. J Clin Invest 1996 Sep 1; 98(5): 1231-6.
19. Henry RR, Abrams L, Nikoulina S, Ciaraldi TP. Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures. Diabetes 1995 Aug; 44(8): 936-46.
20. Gaster M, Petersen I, Hojlund K, Poulsen P, Beck-Nielsen H. The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity. Diabetes 2002 Apr; 51(4): 921-7.
21. Nikoulina SE, Ciaraldi TP, Carter L, Mudaliar S, Park KS, Henry RR. Impaired muscle glycogen synthase in type 2 diabetes is associated with diminished phosphatidylinositol 3-kinase activation. J Clin Endocrinol Metab 2001 Sep; 86(9): 4307-14.
22. Bouzakri K, Roques M, Gual P, et al. Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes. Diabetes 2003 Jun; 52(6): 1319-25.
23. Saltin B, Gollnick D. Skeletal muscle adaptability: significance for metabolism and performance. In: Peachey LD, Adrian RH, Geiger SR, editors. Handbook of Physiology. Baltimore: Williams & Wilkins; 1983. p. 555-631.
24. Kelley DE, Reilly JP, Veneman T, Mandarino LJ. Effects of insulin on skeletal muscle glucose storage, oxidation, and glycolysis in humans. Am J Physiol 1990 Jun; 258(6 Pt 1): E923-E929.
25. Kelley DE, Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 2000 May; 49(5): 677-83.
26. Kelley DE, Simoneau JA. Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest 1994 Dec; 94(6): 2349-56.
27. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963 Apr 13; 1: 785-9.
28. Sidossis LS, Stuart CA, Shulman GI, Lopaschuk GD, Wolfe RR. Glucose plus insulin regulate fat oxidation by controlling the rate of fatty acid entry into the mitochondria. J Clin Invest 1996 Nov 15; 98(10): 2244-50.
29. Turcotte LP, Swenberger JR, Yee AJ. High carbohydrate availability increases LCFA uptake and decreases LCFA oxidation in perfused muscle. Am J Physiol Endocrinol Metab 2002 Jan; 282(1): E177-E183.
30. Sidossis LS, Wolfe RR. Glucose and insulin-induced inhibition of fatty acid oxidation: the glucose-fatty acid cycle reversed. Am J Physiol 1996 Apr; 270(4 Pt 1): E733-E738.
31. Pan DA, Lillioja S, Kriketos AD, et al. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 1997 Jun; 46(6): 983-8.
32. Phillips DI, Caddy S, Ilic V, et al. Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism 1996 Aug; 45(8): 947-50.
33. Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1alpharesponsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003 Jul; 34(3): 267-73.
34. Patti ME, Butte AJ, Crunkhorn S, et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 2003 Jul 8; 100(14): 8466-71.
35. Blau HM, Webster C. Isolation and characterization of human muscle cells. Proc Natl Acad Sci U S A 1981 Sep; 78(9): 5623-7.
36. Gaster M, Kristensen SR, Beck-Nielsen H, Schroder HD. A cellular model system of differentiated human myotubes. APMIS 2001 Nov; 109(11): 735-44.
37. Gaster M, Beck-Nielsen H, Schroder HD. Proliferation conditions for human satellite cells. The fractional content of satellite cells. APMIS 2001 Nov; 109(11): 726-34.
38. Berg JM, Tymoczko JL, Stryer L. Biochemistry. Seventh Edition edition edn. W. H. Freeman; 2011.
39. Gaster M. Fibre Type Dependent Expression of Glucose Transporters in Human Skeletal Muscles. APMIS 2007 Jul; 115(s121): 1-48.
40. Gaster M, Handberg A, Beck-Nielsen H, Schroder HD. Glucose transporter expression in human skeletal muscle fibers. Am J Physiol Endocrinol Metab 2000 Sep; 279(3): E529-E538.
41. Gaster M, Handberg A, Schurmann A, Joost HG, Beck-Nielsen H, Schroder HD. GLUT11, but not GLUT8 or GLUT12, is expressed in human skeletal muscle in a fibre type-specific pattern. Pflugers Arch 2004 Apr; 448(1): 105-13.
42. Zorzano A, Fandos C, Palacin M. Role of plasma membrane transporters in muscle metabolism. Biochem J 2000 Aug 1; 349 Pt 3: 667-88.
43. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 1981 Dec; 30(12): 1000-7.
44. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1992 Mar; 15(3): 318-68.
45. Gibala MJ, MacLean DA, Graham TE, Saltin B. Tricarboxylic acid cycle intermediate pool size and estimated cycle flux in human muscle during exercise. Am J Physiol 1998 Aug; 275(2 Pt 1): E235-E242.
46. Helge JW, Stallknecht B, Richter EA, Galbo H, Kiens B. Muscle metabolism during graded quadriceps exercise in man. J Physiol 2007 Jun 15; 581(Pt 3): 1247-58.
47. Hue L, Taegtmeyer H. The Randle cycle revisited: a new head for an old hat. Am J Physiol Endocrinol Metab 2009 Sep; 297(3): E578-E591.
48. Bowker-Kinley MM, Davis WI, Wu P, Harris RA, Popov KM. Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex. Biochem J 1998 Jan 1; 329 (Pt 1): 191-6.
49. Huang B, Gudi R, Wu P, Harris RA, Hamilton J, Popov KM. Isoenzymes of pyruvate dehydrogenase phosphatase. DNA-derived amino acid sequences, expression, and regulation. J Biol Chem 1998 Jul 10; 273(28): 17680-8.
50. McGarry JD, Mills SE, Long CS, Foster DW. Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. Biochem J 1983 Jul 15; 214(1): 21-8.
51. Winder WW, Arogyasami J, Barton RJ, Elayan IM, Vehrs PR. Muscle malonyl-CoA decreases during exercise. J Appl Physiol 1989 Dec; 67(6): 2230-3.
52. Abu-Elheiga L, Brinkley WR, Zhong L, Chirala SS, Woldegiorgis G, Wakil SJ. The subcellular localization of acetyl-CoA carboxylase 2. Proc Natl Acad Sci U S A 2000 Feb 15; 97(4): 1444-9.
53. Mandard S, Muller M, Kersten S. Peroxisome proliferatoractivated receptor alpha target genes. Cell Mol Life Sci 2004 Feb; 61(4): 393-416.
54. Holness MJ, Sugden MC. Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation. Biochem Soc Trans 2003 Dec; 31(Pt 6): 1143-51.
55. Postic C, Dentin R, Denechaud PD, Girard J. ChREBP, a transcriptional regulator of glucose and lipid metabolism. Annu Rev Nutr 2007; 27: 179-92.
56. Hardie DG, Carling D, Carlson M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 1998; 67: 821-55.
57. McBride A, Hardie DG. AMP-activated protein kinase--a sensor of glycogen as well as AMP and ATP? Acta Physiol (Oxf) 2009 May; 196(1): 99-113.
58. Treebak JT, Glund S, Deshmukh A, et al. AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits. Diabetes 2006 Jul; 55(7): 2051-8.
59. Dyck JR, Kudo N, Barr AJ, Davies SP, Hardie DG, Lopaschuk GD. Phosphorylation control of cardiac acetyl-CoA carboxylase by cAMP-dependent protein kinase and 5'-AMP activated protein kinase. Eur J Biochem 1999 May; 262(1): 184-90.
60. Yasin R, Van BG, Nurse KC, Al-Ani S, Landon DN, Thompson EJ. A quantitative technique for growing human adult skeletal muscle in culture starting from mononucleated cells. J Neurol Sci 1977 Jul; 32(3): 347-60.
61. Dohm GL, Tapscott EB, Pories WJ, et al. An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. J Clin Invest 1988 Aug; 82(2): 486-94.
62. Askanas V, Engel WK. A new program for investigating adult human skeletal muscle grown aneurally in tissue culture. Neurology 1975 Jan; 25(1): 58-67.
63. Meola G. Hereditary human myopathies in muscle culture. Ital J Neurol Sci 1991 Jun; 12(3): 257-68.
64. Miranda AF, Mongini T, DiMauro S. Human myopathies in muscle culture: morphological, cytochemical, and biochemical studies. Advances in cell culture, vol.4. 1984.
65. Miranda AF, Mongini T. Diseased Muscle in Tissue Culture. Myology.Basic and Clinical.New York: McGraw-Hill Book co; 1986. p. 1123-49.
66. Bouzakri K, Zachrisson A, Al-Khalili L, et al. siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle. Cell Metab 2006 Jul; 4(1): 89-96.
67. Kausch C, Krutzfeldt J, Witke A, et al. Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells. Biochem Biophys Res Commun 2001 Jan 26; 280(3): 664-74.
68. Krutzfeldt J, Kausch C, Volk A, et al. Insulin signaling and action in cultured skeletal muscle cells from lean healthy humans with high and low insulin sensitivity. Diabetes 2000 Jun; 49(6): 992-8.
69. Ciaraldi TP, Abrams L, Nikoulina S, Mudaliar S, Henry RR. Glucose transport in cultured human skeletal muscle cells. Regulation by insulin and glucose in nondiabetic and non-insulindependent diabetes mellitus subjects. J Clin Invest 1995 Dec; 96(6): 2820-7.
70. Henry RR, Ciaraldi TP, Mudaliar S, Abrams L, Nikoulina SE. Acquired defects of glycogen synthase activity in cultured human skeletal muscle cells: influence of high glucose and insulin levels. Diabetes 1996 Apr; 45(4): 400-7.
71. Gaster M, Rustan AC, Aas V, Beck-Nielsen H. Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes. Diabetes 2004 Mar; 53(3): 542-8.
72. Gaster M, Brusgaard K, Handberg A, Hojlund K, Wojtaszewski JF, Beck-Nielsen H. The primary defect in glycogen synthase activity is not based on increased glycogen synthase kinase-3alpha activity in diabetic myotubes. Biochem Biophys Res Commun 2004 Jul 9; 319(4): 1235-40.
73. Gaster M, Beck-Nielsen H. The Reduced Insulin Mediated Glucose Oxidation in Skeletal Muscle from Type 2 Diabetic Subjects may be of Genetic Origin - Evidence from Cultured Myotubes. Biochim Biophys Acta 2004; 1690: 85-91.
74. Gaster M. Reduced TCA flux in diabetic myotubes: A governing influence on the diabetic phenotype? Biochem Biophys Res Commun 2009 Oct 2; 387(4): 651-5.
75. Gaster M. Reduced lipid oxidation in myotubes established from obese and type 2 diabetic subjects. Biochem Biophys Res Commun 2009 May 15; 382(4): 766-70.
76. Abdallah BM, Beck-Nielsen H, Gaster M. Increased expression of 11beta-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes. Eur J Clin Invest 2005 Oct; 35(10): 627-34.
77. Gaster M, Beck-Nielsen H. Triacylglycerol accumulation is not primarily affected in myotubes established from type 2 diabetic subjects. Biochim Biophys Acta 2006 Jan; 1761(1): 100-10.
78. Just M, Faergeman NJ, Knudsen J, Beck-Nielsen H, Gaster M. Long-chain Acyl-CoA is not primarily increased in myotubes established from type 2 diabetic subjects. Biochim Biophys Acta 2006 May 23; 1762(7): 666-72.
79. Mauro A. Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 1961 Feb; 9: 493-5.
80. Gaster M. in vitro modelsystem for human skelet muskulatur. PhD Thesis. University of Southern Denmark. 1999.
81. Bonavaud S, Agbulut O, D'Honneur G, Nizard R, Mouly V, Butler- Browne G. Preparation of isolated human muscle fibers: a technical report. In Vitro Cell Dev Biol Anim 2002 Feb; 38(2): 66-72.
82. Benders AA, van Kuppevelt TH, Oosterhof A, Veerkamp JH. The biochemical and structural maturation of human skeletal muscle cells in culture: the effect of the serum substitute Ultroser G. Exp Cell Res 1991 Aug; 195(2): 284-94.
83. Nehlin JO, Just M, Rustan AC, Gaster M. Human myotubes from myoblast cultures undergoing senescence exhibit defects in glucose and lipid metabolism. Biogerontology 2011 Apr 22; 12(4): 349-65.
84. Johnson MA FAU, Polgar JF, Weightman DF, Appleton D. Data on the distribution of fibre types in thirty-six human muscles. An autopsy study. J Neurosci Res 1973; 18(0022-510X): 118-29.
85. Mouly V, Edom F, Barbet JP, Butler-Browne GS. Plasticity of human satellite cells. Neuromuscul Disord 1993 Sep; 3(5-6): 371-7.
86. Bonavaud S, Agbulut O, Nizard R, D'Honneur G, Mouly V, Butler- Browne G. A discrepancy resolved: human satellite cells are not preprogrammed to fast and slow lineages. Neuromuscul Disord 2001 Nov; 11(8): 747-52.
87. Wilmsen HM, Ciaraldi TP, Carter L, Reehman N, Mudaliar SR, Henry RR. Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects. Am J Physiol Endocrinol Metab 2003 Aug; 285(2): E354-E362.
88. Muoio DM, Way JM, Tanner CJ, et al. Peroxisome proliferatoractivated receptor-alpha regulates fatty acid utilization in primary human skeletal muscle cells. Diabetes 2002 Apr; 51(4): 901-9.
89. Lund S, Holman GD, Zierath JR, et al. Effect of insulin on GLUT4 cell surface content and turnover rate in human skeletal muscle as measured by the exofacial bis-mannose photolabeling technique. Diabetes 1997 Dec; 46(12): 1965-9.
90. Al-Khalili L, Chibalin AV, Kannisto K, et al. Insulin action in cultured human skeletal muscle cells during differentiation: assessment of cell surface GLUT4 and GLUT1 content. Cell Mol Life Sci 2003 May; 60(5): 991-8.
91. Thingholm TE, Bak S, Beck-Nielsen H, Jensen ON, Gaster M. Characterization of human myotubes from type 2 diabetic and nondiabetic subjects using complementary quantitative mass spectrometric methods. Mol Cell Proteomics 2011 Sep; 10(9): M110.
92. Handberg A, Vaag A, Damsbo P, Beck-Nielsen H, Vinten J. Expression of insulin regulatable glucose transporters in skeletal muscle from type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1990 Oct; 33(10): 625-7.
93. Pedersen O, Bak JF, Andersen PH, et al. Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 1990 Jul; 39(7): 865-70.
94. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004 Jun; 89(6): 2745-9.
95. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998 Sep; 83(9): 3078-82.
96. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004 Jan; 19(1): 41-7.
97. Eriksen M, Porneki AD, Skov V, et al. Insulin Resistance Is Not Conserved in Myotubes Established from Women with PCOS. PLoS One 2010; 5(12): e14469. Available from: http: //plosone.org/article//info%3Adoi%2F10.1371%2Fjournal.pone.0014469
98. Glintborg D, Hojlund K, Andersen NR, Hansen BF, Beck-Nielsen H, Wojtaszewski JF. Impaired insulin activation and dephosphorylation of glycogen synthase in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment. J Clin Endocrinol Metab 2008 Sep; 93(9): 3618-26.
99. Skov V, Glintborg D, Knudsen S, et al. Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome. Diabetes 2007 Sep; 56(9): 2349-55.
100. Eriksen MB, Minet AD, Glintborg D, Gaster M. Intact primary mitochondrial function in myotubes established from women with PCOS. J Clin Endocrinol Metab 2011 Aug; 96(8): E1298-E1302.
101. Lillioja S, Young AA, Culter CL, et al. Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 1987 Aug; 80(2): 415-24.
102. Kriketos AD, Pan DA, Lillioja S, et al. Interrelationships between muscle morphology, insulin action, and adiposity. Am J Physiol 1996 Jun; 270(6 Pt 2): R1332-R1339.
103. Hickey MS, Carey JO, Azevedo JL, et al. Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans. Am J Physiol 1995 Mar; 268(3 Pt 1): E453-E457.
104. Gaster M, Staehr P, Beck-Nielsen H, Schroder HD, Handberg A. GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients: is insulin resistance in type 2 diabetes a slow, type 1 fiber disease? Diabetes 2001 Jun; 50(6): 1324-9.
105. He J, Watkins S, Kelley DE. Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes 2001 Apr; 50(4): 817-23.
106. Kelley DE, Mokan M, Simoneau JA, Mandarino LJ. Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 1993 Jul; 92(1): 91-8.
107. Kelley D, Mokan M, Veneman T. Impaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus. Metabolism 1994 Dec; 43(12): 1549-57.
108. Gaster M. Substrate overload: Glucose oxidation in human myotubes conquers palmitate oxidation through anaplerosis. Biochem Biophys Res Commun 2010 Jan 15; 391(3): 1369-73.
109. Gaster M. Metabolic flexibility is conserved in diabetic myotubes. J Lipid Res 2007 Jan; 48(1): 207-17.
110. Gaster M. The Dynamic of lipid oxidation in human myotubes. Biochim Biophys Acta 2009; 1791: 17-24.
111. Listenberger LL, Han X, Lewis SE, et al. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci U S A 2003 Mar 18; 100(6): 3077-82.
112. Listenberger LL, Ory DS, Schaffer JE. Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J Biol Chem 2001 May 4; 276(18): 14890-5.
113. Koves TR, Ussher JR, Noland RC, et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 2008 Jan; 7(1): 45-56.
114. Gaster M, Schroder HD, Handberg A, Beck-Nielsen H. The basal kinetic parameters of glycogen synthase in human myotube cultures are not affected by chronic high insulin exposure. Biochim Biophys Acta 2001 Nov 29; 1537(3): 211-21.
115. Hurel SJ, Rochford JJ, Borthwick AC, et al. Insulin action in cultured human myoblasts: contribution of different signalling pathways to regulation of glycogen synthesis. Biochem J 1996 Dec 15; 320 (Pt 3): 871-7.
116. Hajduch E, Litherland GJ, Hundal HS. Protein kinase B (PKB/Akt)--a key regulator of glucose transport? FEBS Lett 2001 Mar 16; 492(3): 199-203.
117. Jackson S, Bagstaff SM, Lynn S, Yeaman SJ, Turnbull DM, Walker M. Decreased insulin responsiveness of glucose uptake in cultured human skeletal muscle cells from insulin-resistant nondiabetic relatives of type 2 diabetic families. Diabetes 2000 Jul; 49(7): 1169-77.
118. Pender C, Goldfine ID, Kulp JL, et al. Analysis of insulinstimulated insulin receptor activation and glucose transport in cultured skeletal muscle cells from obese subjects. Metabolism 2005 May; 54(5): 598-603.
119. Vollenweider P, Menard B, Nicod P. Insulin resistance, defective insulin receptor substrate 2-associated phosphatidylinositol-3' kinase activation, and impaired atypical protein kinase C (zeta/lambda) activation in myotubes from obese patients with impaired glucose tolerance. Diabetes 2002 Apr; 51(4): 1052-9.
120. McIntyre EA, Halse R, Yeaman SJ, Walker M. Cultured muscle cells from insulin-resistant type 2 diabetes patients have impaired insulin, but normal 5-amino-4-imidazolecarboxamide ribosidestimulated, glucose uptake. J Clin Endocrinol Metab 2004 Jul; 89(7): 3440-8.
121. Gaster M. Insulin resistance and the mitochondrial link. Lessons from cultured human myotubes. Biochim Biophys Acta 2007 Jul; 1772(7): 755-65.
122. Gaster M. Mitochondrial mass is inversely correlated to complete lipid oxidation in human myotubes. Biochem Biophys Res Commun 2011 Jan 28; 404(4): 1023-8.
123. Gaster M, Rustan A, Beck-Nielsen H. Differential utilization of saturated palmitate and unsaturated oleate. Evidence from Cultured Myotubes. Diabetes 2005; 54: 648-56.
124. Ukropcova B, McNeil M, Sereda O, et al. Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor. J Clin Invest 2005 Jul; 115(7): 1934-41.
125. Minet AD, Gaster M. Pyruvate carboxylase is expressed in human skeletal muscle. Biochem Biophys Res Commun 2010 Nov 12; 402(2): 196-7.
126. van Loon LJ, Manders RJ, Koopman R, et al. Inhibition of adipose tissue lipolysis increases intramuscular lipid use in type 2 diabetic patients. Diabetologia 2005 Oct; 48(10): 2097-107.
127. Liu L, Zhang Y, Chen N, Shi X, Tsang B, Yu YH. Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. J Clin Invest 2007 Jun; 117(6): 1679-89.
128. Haemmerle G, Lass A, Zimmermann R, et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 2006 May 5; 312(5774): 734-7.
129. Schenk S, Horowitz JF. Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insulin resistance. J Clin Invest 2007 Jun; 117(6): 1690-8.
130. Wicklmayr M, Dietze G, Rett K, Mehnert H. Evidence for a substrate regulation of triglyceride lipolysis in human skeletal muscle. Horm Metab Res 1985 Sep; 17(9): 471-5.
131. Corpeleijn E, Hessvik NP, Bakke SS, et al. Oxidation of intramyocellular lipids is dependent on mitochondrial function and the availability of extracellular fatty acids. Am J Physiol Endocrinol Metab 2010 Jul; 299(1): E14-E22.
132. Aas V, Hessvik NP, Wettergreen M, et al. Chronic hyperglycemia reduces substrate oxidation and impairs metabolic switching of human myotubes. Biochim Biophys Acta 2011 Jan; 1812(1): 94-105.
133. Aas V, Kase ET, Solberg R, Jensen J, Rustan AC. Chronic hyperglycaemia promotes lipogenesis and triacylglycerol accumulation in human skeletal muscle cells. Diabetologia 2004 Aug; 47(8): 1452-61.
134. Kelley D, Mokan M, Veneman T. Impaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus. Metabolism 1994 Dec; 43(12): 1549-57.
135. Mensink M, Blaak EE, van Baak MA, Wagenmakers AJ, Saris WH. Plasma free Fatty Acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes. Diabetes 2001 Nov; 50(11): 2548-54.
136. Kim JY, Hickner RC, Cortright RL, Dohm GL, Houmard JA. Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab 2000 Nov; 279(5): E1039-E1044.
137. Kase ET, Wensaas AJ, Aas V, et al. Skeletal muscle lipid accumulation in type 2 diabetes may involve the liver X receptor pathway. Diabetes 2005 Apr; 54(4): 1108-15.
138. Befroy DE, Petersen KF, Dufour S, et al. Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients. Diabetes 2007 May; 56(5): 1376-81.
139. Schrauwen P, Hesselink MK. Reduced tricarboxylic acid cycle flux in type 2 diabetes mellitus? Diabetologia 2008 Sep; 51(9): 1694-7.
140. Ortenblad N, Mogensen M, Petersen I, et al. Reduced insulinmediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect. Biochim Biophys Acta 2005 Jun 30; 1741(1-2): 206-14.
141. Janssen AJ, Trijbels FJ, Sengers RC, et al. Measurement of the energy-generating capacity of human muscle mitochondria: diagnostic procedure and application to human pathology. Clin Chem 2006 May; 52(5): 860-71.
142. Gaster M, Nehlin JO, Minet AD. Impaired TCA cycle flux in mitochondria in skeletal muscle from Type 2 diabetic subjects: Marker or Maker of the diabetic phenotype? Archives Of Physiology And Biochemistry 2012; (DOi: 10.3109/13813455.2012.656653): In Press.
143. Frederiksen CM, Hojlund K, Hansen L, et al. Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes. Diabetologia 2008 Aug 22; 51(11): 2068-77.
144. Huttemann M, Lee I, Samavati L, Yu H, Doan JW. Regulation of mitochondrial oxidative phosphorylation through cell signaling. Biochim Biophys Acta 2007 Dec; 1773(12): 1701-20.
145. Lin G, Brownsey RW, MacLeod KM. Regulation of mitochondrial aconitase by phosphorylation in diabetic rat heart. Cell Mol Life Sci 2009 Mar; 66(5): 919-32.
146. Minet AD, Gaster M. Hydrogen peroxide production is not primarily increased in human myotubes established from type 2 diabetic subjects. J Clin Endocrinol Metab 2011 Sep; 96(9): E1486-E1490.
147. Halse R, Fryer LG, McCormack JG, Carling D, Yeaman SJ. Regulation of glycogen synthase by glucose and glycogen: a possible role for AMP-activated protein kinase. Diabetes 2003 Jan; 52(1): 9-15.
148. Brown AE, Elstner M, Yeaman SJ, Turnbull DM, Walker M. Does impaired mitochondrial function affect insulin signaling and action in cultured human skeletal muscle cells? Am J Physiol Endocrinol Metab 2008 Jan; 294(1): E97-102.
149. Minet AD, Gaster M. ATP synthesis is impaired in isolated mitochondria from myotubes established from type 2 diabetic subjects. Biochem Biophys Res Commun 2010 Nov 5; 402(1): 70-4.
150. Minet AD, Gaster M. The dynamic equilibrium between ATP synthesis and ATP consumption is lower in isolated mitochondria from myotubes established from type 2 diabetic subjects compared to lean control. Biochem Biophys Res Commun 2011 Jun 17; 409(4): 591-5.
151. Chen YD, Varasteh BB, Reaven GM. Plasma lactate concentration in obesity and type 2 diabetes. Diabete Metab 1993 Jul; 19(4): 348-54.
152. Lovejoy J, Mellen B, Digirolamo M. Lactate generation following glucose ingestion: relation to obesity, carbohydrate tolerance and insulin sensitivity. Int J Obes 1990 Oct; 14(10): 843-55.
153. Hojlund K, Mustard KJ, Staehr P, et al. AMPK activity and isoform protein expression are similar in muscle of obese subjects with and without type 2 diabetes. Am J Physiol Endocrinol Metab 2004 Feb; 286(2): E239-E244.
154. Jeoung NH, Harris RA. Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice. Am J Physiol Endocrinol Metab 2008 Jul; 295(1): E46-E54.
155. Kulkarni SS, Salehzadeh F, Fritz T, Zierath JR, Krook A, Osler ME. Mitochondrial regulators of fatty acid metabolism reflect metabolic dysfunction in type 2 diabetes mellitus. Metabolism 2012 Feb; 61(2): 175-85.
156. Peters SJ, Harris RA, Wu P, Pehleman TL, Heigenhauser GJ, Spriet LL. Human skeletal muscle PDH kinase activity and isoform expression during a 3-day high-fat/low-carbohydrate diet. Am J Physiol Endocrinol Metab 2001 Dec; 281(6): E1151-E1158.
157. Pilegaard H, Neufer PD. Transcriptional regulation of pyruvate dehydrogenase kinase 4 in skeletal muscle during and after exercise. Proc Nutr Soc 2004 May; 63(2): 221-6.
158. Lee FN, Zhang L, Zheng D, Choi WS, Youn JH. Insulin suppresses PDK-4 expression in skeletal muscle independently of plasma FFA. Am J Physiol Endocrinol Metab 2004 Jul; 287(1): E69-E74.
159. Gaster M. Fibre type dependent expression of glucose transporters in human skeletal muscles. APMIS Suppl 2007; (121): 6-47.
160. Tsao TS, Li J, Chang KS, et al. Metabolic adaptations in skeletal muscle overexpressing GLUT4: effects on muscle and physical activity. FASEB J 2001 Apr; 15(6): 958-69.
161. Yan J, Young ME, Cui L, Lopaschuk GD, Liao R, Tian R. Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in dietinduced obesity. Circulation 2009 Jun 2; 119(21): 2818-28.
162. Mandarino LJ, Consoli A, Jain A, Kelley DE. Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM. Am J Physiol 1996 Mar; 270(3 Pt 1): E463-E470.
163. Ellis BA, Poynten A, Lowy AJ, et al. Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am J Physiol Endocrinol Metab 2000 Sep; 279(3): E554-E560.
164. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 2002 Jul; 51(7): 2005-11.
165. Galgani JE, Heilbronn LK, Azuma K, et al. Metabolic flexibility in response to glucose is not impaired in people with type 2 diabetes after controlling for glucose disposal rate. Diabetes 2008 Apr; 57(4): 841-5.
166. Schrauwen-Hinderling VB, Roden M, Kooi ME, Hesselink MK, Schrauwen P. Muscular mitochondrial dysfunction and type 2 diabetes mellitus. Curr Opin Clin Nutr Metab Care 2007 Nov; 10(6): 698-703.
167. Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, Jeneson JA, Backes WH, van Echteld CJ, et al. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia 2007 Jan; 50(1): 113-20.
168. Mogensen M, Sahlin K, Fernstrom M, et al. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 2007 Jun; 56(6): 1592-9.
169. Rabol R, Boushel R, Dela F. Mitochondrial oxidative function and type 2 diabetes. Appl Physiol Nutr Metab 2006 Dec; 31(6): 675-83.
170. Andersen P, Saltin B. Maximal perfusion of skeletal muscle in man. J Physiol 1985 Sep; 366: 233-49.
171. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004 Feb 12; 350(7): 664-71.
172. Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsoe R, Dela F. Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 2007 Apr; 50(4): 790-6.
173. Hey-Mogensen M, Hojlund K, Vind BF, et al. Effect of physical training on mitochondrial respiration and reactive oxygen species release in skeletal muscle in patients with obesity and type 2 diabetes. Diabetologia 2010 Sep; 53(9): 1976-85.
174. Gaster M. Reduced TCA flux in diabetic myotubes: Determined by single defects? Biochimistry Research International 2012: 716056. Available from: http: //www.hindawi.com/journals/bcri/2012/ 716056/
175. Meigs JB, Larson MG, Fox CS, Keaney JF, Jr., Vasan RS, Benjamin EJ. Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham Offspring Study. Diabetes Care 2007 Oct; 30(10): 2529-35.
176. Abdul-Ghani MA, Jani R, Chavez A, Molina-Carrion M, Tripathy D, DeFronzo RA. Mitochondrial reactive oxygen species generation in obese non-diabetic and type 2 diabetic participants. Diabetologia 2009 Apr; 52(4): 574-82.
177. Hojlund K, Staehr P, Hansen BF, et al. Increased Phosphorylation of Skeletal Muscle Glycogen Synthase at NH(2)-Terminal Sites During Physiological Hyperinsulinemia in Type 2 Diabetes. Diabetes 2003 Jun; 52(6): 1393-402.
178. Kelley DE, Williams KV, Price JC, McKolanis TM, Goodpaster BH, Thaete FL. Plasma fatty acids, adiposity, and variance of skeletal muscle insulin resistance in type 2 diabetes mellitus. J Clin Endocrinol Metab 2001 Nov; 86(11): 5412-9.
179. Dresner A, Laurent D, Marcucci M, et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3- kinase activity. J Clin Invest 1999 Jan; 103(2): 253-9.
180. Griffin ME, Marcucci MJ, Cline GW, et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 1999 Jun; 48(6): 1270-4.
181. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3- kinase activity in muscle. J Biol Chem 2002 Dec 27; 277(52): 50230-6.
182. Muoio DM, Newgard CB. Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 2008 Mar; 9(3): 193-205.
183. Muoio DM, Newgard CB. Obesity-related derangements in metabolic regulation. Annu Rev Biochem 2006; 75: 367-401.
184. Gaster M. Metabolic flexibility is conserved in diabetic myotube. 2006.